(Health-NewsWire.Net, February 22, 2018 ) Chlamydia is a sexually transmitted disease. The symptoms do not occur early on. It is usually prevalent in areas with poor sanitation. It is the most common STD worldwide. Number of victims has been increasing over the last decade.The North America Chlamydia Infection Diagnostics and Therapeutics market size was around USD 800 million in 2017. It is expected to grow at a CAGR of 5.6% to reach USD 1.05 billion by 2022. It captures 40% of the global market
Increasing number of cases of these diseases better and complete reporting in emerging economies, augmenting screening coverage, improved funding for better R&D in this area, growing awareness regarding STDs in the developing countries along with the increased healthcare expenditures are the factors driving the growth of this market. Also accessibility to and availability of hyper sensitive diagnostic tests are also boosting the growth of this market. Furthermore, improved insurance coverage in the emerging economies augurs well for this market.However, the stigma associated with sexually transmitted diseases is the primary restraint of market growth.
Get free research sample report at https://www.marketdataforecast.com/market-reports/north-america-chlamydia-infection-diagnostics-and-therapeutics-market-5138/request-sample
This market is broadly segmented by product type and end user into diagnostics and therapeutics segments. Classification in diagnostics by product type entails Nucleic Acid Amplification Tests (NAATs), Direct Fluorescent Tests, and PCR. NAAT accounted for the largest market share in 2016 and is predicted to grow robustly in the forecast period. It is closely tailed by DFT in terms of CAGR. This is because NAATs are more sensitive and diagnose better. Classification in diagnostics by end user entails Hospitals, Specialty Clinics, and Diagnostic Centres. Classification in therapeutics by product type entails Macrolides, Quinolones, Sulphonamides, Tetracycline, and Aminopenicillins. Macrolides is expected to undergo high growth in the forecast period. It also captures the largest market share and is expected to stay at the top in the forecast period. Classification in therapeutics by end user entails Hospital Pharmacies, Drugstores, Retail Pharmacies, and Online Pharmacies.
Classification by geography entails US and Canada. North American market raked in the highest revenue in 2016. Thriving healthcare industry, increasing number of victims, well establishment reimbursement policies both from the government and the private sector and economical treatment because of the higher awareness are the reasons attributable to the observable trend mentioned above.
Key players in the market include Bio Rad laboratories, Novartis AG, F Hoffmann-La Roche, Abbott Laboratories, Danaher. Other players in the market include bioMerieux, DiaSorin SpA, Siemens AG, Thermo Fisher Scientific, and Becton Dickinson and Company.
Scope of the report
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
About Market Data Forecast
Being a familiar face to the Fortune 500 companies in the field of market research, Market Data Forecast provides its clientele with research material through syndicated reports, consult projects and industry newsletters across various domains and verticals. Our in-house research panel, comprises of industry experts, vertical/domain specialists, supported by a well-built research & data models that help in providing insights for making well-informed decisions. We have a well-established data gathering network across 100+ countries through tie-ups and collaboration’s with the key personnel in value chains & local research organizations. Apart the excellent research services, we also boast of unique post-purchase services offering a 24*7 analyst support for the period of six months. Further, though a continuous feedback from our users, clients and experts, we keep on innovating ourselves in this field to support the organizations in the most efficient ways.
Market Data Forecast
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|